Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michio Sata

Showing results (21-30 of 416) with videos related to

Pageof 42
Sort By:
Journal of Gastroenterology|February 8, 2003
Intestinal microflora as a therapeutic target in inflammatory bowel diseaseKeiichi Mitsuyama, Atsushi Toyonaga, Michio Sata
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 23, 2011
Do the national survey results reflect the state of drug-induced liver injury in a single local city in which there is no hospital having Members of the Board of Councilors of the Japan Society of Hepatology? Results of a questionnaire survey conducted in a local cityAkiko Hisamochi, Ryukichi Kumashiro, Michio Sata
Journal of Gastroenterology and Hepatology|April 10, 2008
Insulin resistance and lichen planus in patients with HCV-infectious liver diseasesYumiko Nagao, Katsuya Kawasaki, Michio Sata
Journal of Diabetes and Its Complications|August 7, 2012
Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetesTadashi Iwao, Kenji Sakai, Michio Sata
BMC Gastroenterology|November 6, 2012
Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseasesYumiko Nagao, Kouji Hashimoto, Michio Sata
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|February 28, 2006
[Obesity and liver diseases]Michio Sata, Takato Ueno, Yasuyo Morita
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 14, 2004
[Survey of hepatitis B and C in students of faculty of dentistry and dental hygienist school]Yumiko Nagao, Itsuo Chibo, Michio Sata
Hepatitis Monthly|March 5, 2015
Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infectionYumiko Nagao, Yuji Kawahigashi, Michio Sata
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 22, 2010
[Clinical analysis of cat scratch disease]Hiroshi Yoshida, Nobuhide Kusaba, Michio Sata
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 14, 2004
[Routes of transmission of hepatitis C virus in hyperendemic areas, and molecular epidemiologic study of hepatitis C virus infection]Kazuo Tanaka, Tatsuya Ide, Michio Sata
Pageof 42

Showing results (21-30 of 416) with videos related to

Sort By:
Pageof 42
Journal of Gastroenterology|February 8, 2003
Intestinal microflora as a therapeutic target in inflammatory bowel diseaseKeiichi Mitsuyama, Atsushi Toyonaga, Michio Sata
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 23, 2011
Do the national survey results reflect the state of drug-induced liver injury in a single local city in which there is no hospital having Members of the Board of Councilors of the Japan Society of Hepatology? Results of a questionnaire survey conducted in a local cityAkiko Hisamochi, Ryukichi Kumashiro, Michio Sata
Journal of Gastroenterology and Hepatology|April 10, 2008
Insulin resistance and lichen planus in patients with HCV-infectious liver diseasesYumiko Nagao, Katsuya Kawasaki, Michio Sata
Journal of Diabetes and Its Complications|August 7, 2012
Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetesTadashi Iwao, Kenji Sakai, Michio Sata
BMC Gastroenterology|November 6, 2012
Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseasesYumiko Nagao, Kouji Hashimoto, Michio Sata
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|February 28, 2006
[Obesity and liver diseases]Michio Sata, Takato Ueno, Yasuyo Morita
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 14, 2004
[Survey of hepatitis B and C in students of faculty of dentistry and dental hygienist school]Yumiko Nagao, Itsuo Chibo, Michio Sata
Hepatitis Monthly|March 5, 2015
Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infectionYumiko Nagao, Yuji Kawahigashi, Michio Sata
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 22, 2010
[Clinical analysis of cat scratch disease]Hiroshi Yoshida, Nobuhide Kusaba, Michio Sata
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 14, 2004
[Routes of transmission of hepatitis C virus in hyperendemic areas, and molecular epidemiologic study of hepatitis C virus infection]Kazuo Tanaka, Tatsuya Ide, Michio Sata
Pageof 42